AMRN
Companies
NASDAQ
Amarin Corporation plc - ADR
Health Care
$13.33
+$3.53 (+36.02%)
Price Chart
Overview
About AMRN
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
Market Cap
$276.5M
Volume
1.3M
Avg. Volume
1.5M
P/E Ratio
-52.904762
Dividend Yield
0.00%
Employees
461.0
Company Information
Exchange
NASDAQ
Sector
Health Care
Industry
Drug Manufacturers - General
Website
Risk & Correlation Analysis
Market Correlation
0.97
Moderate Correlation
Volatility
High (0.73)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, AMRN shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$276.5M
Volume1.3M
P/E Ratio-52.90
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 7, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025